Personal information

Biography

I am a Clinical Academic in Haematology and Genomic Medicine hosted by the University of Bristol, UK. My research interests include the aetiology and mechanism of rare blood disorders. I have held a series of senior leadership roles within the NHS Genomic Medicine Service since 2017, currently Research Director of the SW England Genomic Medicine Service Alliance. My clinical practice is in Adult and Paediatric bleeding and thrombotic disorders.

Activities

Employment (3)

SW NHS Genomic Medicine Service Alliance: Exeter, GB

2022 to present | Research Director (SW NHS Genomic Medicine Service Alliance)
Employment
Source: Self-asserted source
andrew mumford

University of Bristol: Bristol, GB

2017 to present | Professor of Haematology (School of Cellular and Molecular Medicine)
Employment
Source: Self-asserted source
andrew mumford

University Hospitals Bristol NHS Foundation Trust: Bristol, GB

2007 to present | Honorary Consultant in Haematology (Specialised services)
Employment
Source: Self-asserted source
andrew mumford

Education and qualifications (5)

Imperial College London: London, GB

2003 to present | PhD
Qualification
Source: Self-asserted source
andrew mumford

Royal College of Pathologists: London, GB

2002 to present | Fellowship
Qualification
Source: Self-asserted source
andrew mumford

Royal College of Physicians: London, GB

1994 to present | Fellowship
Qualification
Source: Self-asserted source
andrew mumford

University of Bristol: Bristol, GB

1991 to present | MB ChB (Bristol Medical School)
Qualification
Source: Self-asserted source
andrew mumford

University of Bristol: Bristol, GB

1988 to present | BSc (Department of Anatomy)
Qualification
Source: Self-asserted source
andrew mumford

Professional activities (9)

NHS England Genomics Research Collaborative: London, GB

2021 to present (Steering group)
Invited position
Source: Self-asserted source
andrew mumford

Randomised Evaluation of COVID19 Therapy (RECOVERY) Programme: Oxford, GB

2020 to present (Steering and writing group)
Invited position
Source: Self-asserted source
andrew mumford

NIHR BioResource: Cambridge, England, GB

2019 to present | Co-lead (Bleeding and Platelet Disorders study)
Invited position
Source: Self-asserted source
andrew mumford

Genomics England: London, GB

2019 to present | Co-lead (Haematology Genome Clinical Interpretation Partnership)
Invited position
Source: Self-asserted source
andrew mumford

Health Education England Severn Training Deanery: Brsitol, GB

2014 to present | Director (Haematology Academic Training Programme)
Invited position
Source: Self-asserted source
andrew mumford

SW England NHS Genomic Laboratory Hub: Bristol, GB

2019 to 2022 (Medical Director )
Invited position
Source: Self-asserted source
andrew mumford

NIHR Bristol Biomedical Research Centre: Bristol, GB

2012 to 2021 | Principle Investigator (Cardiac surgery blood conservation programme)
Invited position
Source: Self-asserted source
andrew mumford

West-of-England NHS Genomics Medicine Centre: Bristol, GB

2017 to 2019 (Clinical Director)
Invited position
Source: Self-asserted source
andrew mumford

Bristol NHS Haemophilia Comprehensive Care Centre: Bristol, GB

2002 to 2012 (Centre Founder and Director)
Invited position
Source: Self-asserted source
andrew mumford

Funding (3)

Integrative analysis of whole genomes and transcriptomes from multiple cell types in rare disease patients.

2022-10 to 2027-08 | Grant
National Institutes of Health (Md., Md., US)
Source: Self-asserted source
andrew mumford

Regulatory bench-testing of a transformational polymeric heart valve: a key step toward a first-in-human trial.

2022-09 to 2025-08 | Grant
NIHR Invention for Innovation (i4i) Programme (London, GB)
Source: Self-asserted source
andrew mumford

Aspirin after hospitalisation with Pneumonia to prevent cardiovascular Events randomised Controlled Trial (ASPECT).

2021-11 to 2025-10 | Grant
Health Technology Assessment Programme (London, GB)
Source: Self-asserted source
andrew mumford